Le Lézard
Classified in: Health, Business, Covid-19 virus
Subjects: MAV, FOR, CFG

Media Advisory - Prime Minister's itinerary for Thursday, September 24, 2020


OTTAWA, ON, Sept. 23, 2020 /CNW/ -

Note: All times local

Ottawa, Ontario


Private meetings.


The Prime Minister will participate in a briefing on COVID-19 with the Chief Public Health Officer of Canada, Dr. Theresa Tam.


The Prime Minister will participate in a High-Level Roundtable on Climate Action during the United Nations General Assembly. The virtual event will be livestreamed from 11:30 a.m. to 1:00 p.m. at http://webtv.un.org/.


The Prime Minister will speak with the Prime Minister of Jamaica, Andrew Holness.


10:00 a.m.

The Prime Minister will deliver a statement in the House of Commons on the death of the Right Honourable John N. Turner.


2:00 p.m.

The Prime Minister will attend Question Period.

This document is also available at http://pm.gc.ca

SOURCE Prime Minister's Office


These press releases may also interest you

at 20:31
Club Studio Opens New Location in Kingwood, Texas
Fitness International, LLC opened a new Club Studio location in Kingwood, Texas. The new 40,000 square foot club features five innovative boutique fitness studios that were carefully curated to create a unique experience, along with recovery services...

at 19:35
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mirum Pharmaceuticals, Inc. today announced that on May 10, 2024, the Compensation Committee of Mirum's Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 38,600 shares of common stock and 19,300...

at 19:00
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Evolus, Inc. , a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant of non-qualified stock options to purchase an aggregate of 10,990 shares of Evolus and an aggregate of 42,759...

at 18:36
Inhibrx, Inc. Announces Updated When-Issued Trading Date for Anticipated Spin-Off
Inhibrx, Inc. ("Inhibrx," or the "Company") today announced that in connection with the previously announced distribution by the Company of 92% of shares of common stock of its subsidiary Inhibrx Biosciences, Inc. ("SpinCo") to holders of shares of...

at 17:55
Asia Green Biotechnology Corp. Announces Extension of Management Cease Trade Order
Asia Green Biotechnology Corp. ("Asia Green" or the "Company") announces that, further to its news releases dated April 17, 2024, April 26, 2024, and May 8, 2024, the Management Cease Trade Order ("MCTO") issued by the...

at 17:53
DID YOU PURCHASE AND/OR INGEST U-DREAM IN CANADA ON OR AFTER AUGUST 18, 2014?
The following statement is being issued by Rice Harbut Elliott LLP regarding the Ruckman v. Biotrade Canada Ltd. et al. lawsuit: All persons in Canada who purchased or ingested U-Dream on or after August 18, 2014 (the "Class" or "Class Members")...

More news about Health...


News published on and distributed by: